|
01 Sep 2026
|
Amanta Healthcare
|
Minerva Capital Research Solutions
|
187.42
|
244.00
|
188.80
(-0.73%)
|
30.19 |
Buy
|
|
|
SteriPort (LVP) Expansion : Increase from existing 6.6 Cr. Units to 11.6 Cr. Units with commercial production scheduled in Q2FY 27 ? Incremental revenues at peak potential of INR 110– 120 Cr.
|
|
30 Aug 2025
|
Amanta Healthcare
|
Hem Securities
|
187.42
|
|
|
|
IPO Subscribe
|
|
|
Company is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal (ABFS) and Injection Strech Blow Moulding (ISBM) technology. Company manufacture large volume parenterals (LVPs) and small volume parenterals (SVPs) in six therapeutic segments. In addition to that, company also manufacturer medical devices. Company...
|
|
29 Aug 2025
|
Amanta Healthcare
|
Ventura
|
187.42
|
|
|
|
IPO Subscribe
|
|
|
|